FORT LEE, NEW JERSEY, January 15, 2009 The Stevenson Group, a leading executive search firm, completes the search for four Medical Directors at MedImmune, Inc.
Zafer Ozturk, MD joins MedImmune as Senior Director, Clinical Development – Inflammation. He comes from Hoffman-La Roche and brings over 19 years of experience in the Pharmaceutical industry gained at major pharmaceutical companies such as Sandoz and Merck. As a Medical Director of Immunology at Roche, Dr. Ozturk was responsible for the development of Phase IIIB/IV program for an osteoporosis drug and for leading the US medical team activities including clinical research operations, exploratory data analysis, publication plans, and medical education.
Warren Greth, MD, an experienced Rheumatologist, joins MedImmune as Director, Clinical Development – Inflammation. He also comes from Hoffmann La-Roche, where as an Associate Clinical Director, he was responsible for designing protocols, medical monitoring, and interaction with experts regarding pediatric clinical development programs for juvenile arthritis. While working at Roche, he was also involved in internal clinical data review and provided scientific input for the design of two adult studies in rheumatoid arthritis. Prior to his role at Roche, Dr. Greth was an Associate Clinical Director at Centocor, where he was in charge of medical monitoring of a global trial for psoriatic arthritis.
Dominique Ethgen, MD joins MedImmune as Senior Medical Director, Rheumatology. He is a seasoned senior medical leader with over 20 years of clinical research and drug development experience in musculoskeletal diseases, bone, and rheumatoid arthritis. Prior to joining MedImmune, Dr. Ethgen served as Senior Director, Clinical Development, Immune Mediated Diseases at GlaxoSmithKline. Before his tenure at GSK, Dr. Ethgen spent about nine years at Procter & Gamble Pharmaceuticals where he was involved in bone and mineral clinical research in the US and Europe and the implementation of disease management programs and outcome research studies in Osteoporosis. At MedImmune, Dr. Ethgen will lead clinical development efforts in the areas of Rheumatoid Arthritis, Lupus, and Scleroderma.
Robert Gasser, MD joins MedImmune as Medical Director, Vaccine Development. He comes from the Walter Reed Army Medical Center in Washington, DC, where he most recently served as a Hospital Medicine Physician in the General Internal Medicine Service. At Walter Reed, he supervised direct care provided to hospitalized patients, taught residents and medical students, and conducted research in the infectious diseases arena. Prior to his most recent role, he served as a Deputy Director of Division of Communicable Diseases and Immunology, where he led a biomedical research division of 260 scientists and support staff developing vaccines against endemic tropical diseases.
MedImmune strives to provide better medicines to patients, new medical options for physicians, and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience. With approximately 3,000 employees worldwide, MedImmune is headquartered in Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom and the Netherlands.
The Stevenson Group is an international, retained, executive search firm serving a broad range of clients from early stage venture capital backed companies to Fortune 500 corporations. Our functional experience includes: General Management, Finance, Sales/Marketing, Research & Development, Business Development, Information Technology (IT), Human Resources, and Strategic Consulting. Established in 1979, HQ offices are located in Fort Lee, New Jersey.
Stephen M. Steinman
President & C.E.O. of The Stevenson Group
1530 Palisade Avenue, Fort Lee, NJ 07024, Tel: 201-302-0866 Fax: 201-302-9350